Glimzen Trio 1mg/500mg/0.2mg Tablet SR
Marketer
Indizen Pharmaceutical
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimzen Trio 1mg/500mg/0.2mg Tablet SR
Tridin-G 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults by regulating blood glucose. Tridin-G should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as premature discontinuation, without medical consultation, can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor; lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are typically recommended.
Primary Ingredients of Glimzen Trio 1mg/500mg/0.2mg Tablet SR
No text provided to rephrase.
Uses of Glimzen Trio 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimzen Trio 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; do not chew, crush, or divide it. Consume Glimzen Trio 1mg/500mg/0.2mg Extended-Release Tablets on an empty stomach.
Common Side effects of Glimzen Trio 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimzen Trio 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. Glimzen Trio 1mg/500mg/0.2mg Extended-Release Tablets should be taken on an empty stomach.
How Glimzen Trio 1mg/500mg/0.2mg Tablet SR works:
Glimzen Trio extended-release tablets (1mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimzen Trio 1mg/500mg/0.2mg SR tablets is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimzen Trio tablet (1mg/500mg/0.2mg) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glimzen Trio tablets (1mg/500mg/0.2mg) are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Glimzen Trio 1mg/500mg/0.2mg extended-release tablets are likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimzen Trio 1mg/500mg/0.2mg SR tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should typically begin with a low dose; however, use in patients with severe liver disease is not advised. Consult your physician for guidance.
What if you forget to take Glimzen Trio 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glimzen Trio 1mg/500mg/0.2mg SR tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimzen Trio 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently